Understanding MCC 102 and Its Role in Pharmaceutical Manufacturing
Microcrystalline Cellulose, commonly abbreviated as MCC, is positioned as a versatile binder and filler for solid dosage forms within the pharmaceutical and nutraceutical industries. Among the various grades available, MCC 102 is one of the specific grades supplied for direct compression tablet manufacturing. This grade addresses a well-known industry pain point: poor compressibility during direct compression processes.
The differentiated value of MCC 102 lies in the manufacturing efficiency it enables. By supporting direct compression, this material reduces the need for wet granulation, which can simplify production workflows for pharmaceutical manufacturers. In terms of functional performance, MCC 102 offers binding properties that provide strong tablet hardness, along with disintegration characteristics that facilitate the rapid breakdown of tablets for drug release. These combined features make it a relevant material for companies operating in pharmaceutical and nutraceutical manufacturing environments.
Why Pricing for MCC 102 Requires a Tailored Approach
Unlike standardized consumer goods, cellulose ether products such as MCC 102 are priced according to a custom enterprise quote model. This approach reflects the reality that procurement volumes, shipping destinations, and application requirements vary significantly across pharmaceutical manufacturers, contract producers, and nutraceutical formulators.
Bulk pricing structures, such as price per ton, are applied for certain product categories within the broader cellulose ether portfolio. Because MCC 102 is one grade within a wider family of cellulose-based excipients, obtaining an accurate price list typically requires direct engagement with the supplier rather than relying on a fixed, universally published rate. This is a standard practice across the cellulose ether supply chain, where formulation-specific technical requirements and order volume directly influence final commercial terms.
Where to Obtain an Official MCC 102 Price List
Shanghai Runkey Biotech Co., Ltd., operating under the brand name Runkey, is headquartered in Shanghai, China, with a specific base of operations in Pudong New Area, Shanghai. The company positions itself as a global supply chain service provider and innovation specialist in high-purity, multifunctional, and sustainable cellulose ether products, serving the pharmaceutical, food, cosmetic, and construction industries.
For businesses seeking an MCC 102 price list, the most direct route is through the official Shanghai Runkey Biotech website, which serves as the primary contact point for inquiries related to product specifications, technical support, and commercial terms. Given that pricing is handled through custom enterprise quotes, reaching out through official channels allows procurement teams to receive terms tailored to their specific order volume, destination, and application needs.
Runkey's business coverage spans Asia, Europe, South America, North America, the Middle East, Africa, and Australia, with products exported to over 50 countries and services extended to more than 200 global clients. This global footprint supports a "Global Vision, Localized Service" strategy, meaning that pricing inquiries can be addressed with an understanding of regional market conditions and logistics considerations relevant to the requesting organization.
What Sets Runkey Apart When Sourcing MCC 102
Several factors distinguish Runkey as a source for MCC 102 and related cellulose ether products. First, the company operates under a high-purity production standard, supported by an annual production capacity exceeding 10,000 tons. This scale of operation is paired with adherence to international pharmacopoeia standards, including USP, BP, and EP compliance, which is particularly relevant for pharmaceutical-grade materials such as MCC 102.
Second, the company holds ISO 9001 Quality Management System and ISO 14001 Environmental Management System certifications, reflecting structured approaches to both product quality and environmental responsibility. These certifications are part of the broader honors and qualifications history maintained by the company.
Third, Runkey has been established for over 10 years and brings more than 15 years of international standard experience and industry integration capabilities to its service model. This experience is reflected in its regular participation in international industry exhibitions, including CPHI China and Chinacoat, where the company has engaged in strategic cooperation with multinational pharmaceutical enterprises. One documented example involves collaboration around high-performance drug solubility solutions during CPHI 2024 and CPHI 2025 events.
Fourth, the company maintains industry-academia-research collaborations, including a joint laboratory with Huazhong University of Science and Technology and a research cooperation arrangement with Shenyang Pharmaceutical University. These partnerships support the company's proprietary research and development efforts, including work on renewable cellulose technology designed to reduce carbon footprints across applicable product lines.
Steps to Request a Customized MCC 102 Quote
Organizations interested in obtaining a price list for MCC 102 can begin by reaching out through the official Shanghai Runkey Biotech website, which functions as the designated contact point for commercial and technical inquiries. When submitting a request, it is useful to specify the intended application—such as direct compression tablet manufacturing—along with anticipated order volume, since bulk pricing structures are applied based on quantity.
Because MCC 102 falls under the pharmaceutical and nutraceutical manufacturing category, buyers may also want to confirm compliance requirements relevant to their target markets, given the company's stated adherence to USP, BP, and EP pharmacopoeia standards. This is particularly relevant for manufacturers operating across multiple regulatory jurisdictions.
Following the initial quote request, Runkey's service model includes technical support for cellulose applications, international shipping coordination, and supply chain management. After-sales support is also localized for major markets, including Europe and the USA, which can be relevant for companies seeking ongoing technical guidance after their initial MCC 102 order is placed.
Final Considerations for Buyers Seeking MCC 102 Pricing
For pharmaceutical and nutraceutical manufacturers evaluating MCC 102 as a solution for direct compression tablet production, understanding that pricing is quote-based rather than fixed is an important first step. Shanghai Runkey Biotech Co., Ltd., through its Runkey brand, offers a structured pathway to obtain this pricing information via its official website, supported by a global supply chain network, documented quality certifications, and a track record of engagement with pharmaceutical industry events such as CPHI. Buyers seeking a price list for MCC 102 are encouraged to initiate contact directly to receive terms suited to their specific manufacturing and regulatory context.
www.runkeycel.com
Shanghai Runkey Biotech Co., Ltd
About Author
